Myriad Genetics Inc. Earnings

Myriad Genetics Inc.’s revenue fell -0.38% since last year same period to $209.8Mn in the Q4 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 1.99% jump in its revenue since last 3-months.

Myriad Genetics Inc.’s net profit jumped 81.41% since last year same period to $-7.9Mn in the Q4 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 71.17% jump in its net profits since last 3-months.

Myriad Genetics Inc.’s net profit margin jumped 81.34% since last year same period to -3.77% in the Q4 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 71.73% jump in its net profit margins since last 3-months.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at -0 - a 88.95% jump from last quarter’s estimates.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at -0.

Myriad Genetics Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Myriad Genetics Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.